Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

The effect of rare human sequence variants on the function of vesicular monoamine transporter 2.

Burman J, Tran CH, Glatt C, Freimer NB, Edwards RH.

Pharmacogenetics. 2004 Sep;14(9):587-94.

PMID:
15475732
2.

The VMAT2 gene in mice and humans: amphetamine responses, locomotion, cardiac arrhythmias, aging, and vulnerability to dopaminergic toxins.

Uhl GR, Li S, Takahashi N, Itokawa K, Lin Z, Hazama M, Sora I.

FASEB J. 2000 Dec;14(15):2459-65. Review.

PMID:
11099463
3.

Impact of psychostimulants on vesicular monoamine transporter function.

Fleckenstein AE, Hanson GR.

Eur J Pharmacol. 2003 Oct 31;479(1-3):283-9. Review.

PMID:
14612158
4.

Plasma membrane monoamine transporters: structure, regulation and function.

Torres GE, Gainetdinov RR, Caron MG.

Nat Rev Neurosci. 2003 Jan;4(1):13-25. Review. No abstract available.

PMID:
12511858
5.

Catecholamine metabolism: an update on key biosynthetic enzymes and vesicular monoamine transporters.

Flatmark T, Almas B, Ziegler MG.

Ann N Y Acad Sci. 2002 Oct;971:69-75. Review.

PMID:
12438092
6.

Localization and expression of VMAT2 aross mammalian species: a translational guide for its visualization and targeting in health and disease.

Schafer MK, Weihe E, Eiden LE.

Adv Pharmacol. 2013;68:319-34. doi: 10.1016/B978-0-12-411512-5.00015-4. Review.

7.

[Pharmacological properties and clinical efficacy of tetrabenazine (Choreazine(®)Tablets 12.5 mg), a therapeutic agent for non-rhythmic involuntary movement].

Machida K, Kawakami D, Miki M.

Nihon Yakurigaku Zasshi. 2014 Mar;143(3):144-51. Review. Japanese. No abstract available.

PMID:
24614638

Supplemental Content

Support Center